Research from e27, e27

Research from e27

e27 is Asia's largest Tech media platform. We cover the latest news on emerging and disruptive businesses across the region.

Private Capital Markets

<ul>
<li>Labviva, a Singapore- and US-based AI-driven life sciences digital marketplace, has secured US$20 million in Series A financing led by Biospring Partners.</li>
<li>Existing investors Senator Investment Group, B Capital, and Glasswing Ventures co-invested.</li>
<li>The Series A funding brings the total amount raised since inception to US$30 million.</li>
</ul>


Labviva, a Singapore- and US-based AI-driven life sciences digital marketplace, has secured US$20 million in Series A financing led by Biospring Partners.
Existing investors Senator Investment Group, B Capital, and Glasswing Ventures co-invested.
The Series A funding brings the total amount raised since inception to US$30 million.


B2B Life Sciences Marketplace Labviva Secures US$20M Series A

United States

Labviva, Inc. provides healthcare technology solutions. The Company offers software as a service platform that allows customers to have access to advanced analytics typically not offered by incumbent suppliers. Labviva operates in the United States.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Labviva Inc (1897304D US)

B2B Life Sciences Marketplace Labviva Secures US$20M Series A

Labviva, a Singapore- and US-based AI-driven life sciences digital marketplace, has secured US$20 million in Series A financing led by Biospring...

e27

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)